Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Methicillin-resistant Staphylococcus Aureus (MRSA) Epidemiology Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. Studies ...
Every year, antibiotic-resistant Staphylococcus aureus, commonly known as staph, causes serious infections and outbreaks in ...
A naturally derived molecule shows promise in blocking critical behaviors that bacteria rely on to cause disease.
US FDA grants Fast Track Designation to Armata Pharma’s intravenously administered S. aureus multi-phage product candidate, AP-SA02: Los Angeles Friday, May 8, 2026, 12:00 Hrs [ ...
Hosted on MSN
Flucloxacillin decoded for everyday infections
What it treats: Doctors prescribe flucloxacillin for skin, bone, ear, respiratory, urinary, and soft tissue infections, as well as septicemia and meningitis. How it works: It blocks bacterial cell ...
Initial studies of staphylococcal adhesion focused on binding to the extracellular matrix and plasma proteins. More recently, studies have investigated adhesins for human keratinocytes and their ...
Around 20 percent of all humans are persistently colonized with Staphylococcus aureus bacteria, a leading cause of skin infections and one of the major sources of hospital-acquired infections, ...
What makes S. aureus so dangerous? The virulence of S. aureus lies in its ability to adapt to environmental pressures and immune defenses quickly. A central feature of its survival strategy is the ...
Researchers have identified a mechanism by which the bacterium Staphylococcus aureus colonizes our nasal passages. The study shows for the first time that a protein located on the bacterial surface ...
Researchers provide the first insight into the mode of action of the lipopeptide serrawettin W2-FL10, derived from Serratia marcescens. This lipopeptide targets the cell membrane of S. aureus, causing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results